{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "1243775", "DateCompleted": {"Year": "1976", "Month": "07", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"Language": ["ger"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0377-2004", "JournalIssue": {"Volume": "2", "Issue": "4", "PubDate": {"Year": "1975"}}, "Title": "Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology", "ISOAbbreviation": "Osterr Z Onkol"}, "ArticleTitle": "[Phospholipids under combined ozone-oxygen administration].", "Pagination": {"StartPage": "94", "EndPage": "97", "MedlinePgn": "94-7"}, "Abstract": {"AbstractText": ["The parenterally application of oxygen-ozone gas mixture gives good resultats in the treatment of various deseases. Ozone seems to influence the metabolic process of fat, so it was of interest to analyse this influence especially to phospholipids. 40 women with gynaecological cancer got 10 ml oxygen-ozone gas mixture with a content of 450 gamma ozone into the cubital vene. Venous blood was removed before and 10 minutes after application and the level of lecithin, lysolecithin, cephalin and spingomyelin was determined by the method of Randerath. A decrease of all four substances was obvious, although all values remained in normal range."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "M\u00fcller-Tyl", "ForeName": "E", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hernuss", "ForeName": "P", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Salzer", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Reisinger", "ForeName": "L", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wash\u00fcttl", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wurst", "ForeName": "F", "Initials": "F"}], "PublicationTypeList": ["English Abstract", "Journal Article"], "VernacularTitle": "Phospholipide unter parenteraler ozon-sauerstoff-gemisch-applikation."}, "MedlineJournalInfo": {"Country": "Austria", "MedlineTA": "Osterr Z Onkol", "NlmUniqueID": "7507343", "ISSNLinking": "0377-2004"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Lysophosphatidylcholines"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphatidylcholines"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphatidylethanolamines"}, {"RegistryNumber": "0", "NameOfSubstance": "Phospholipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Sphingomyelins"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["blood", "therapy"], "DescriptorName": "Genital Neoplasms, Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Lysophosphatidylcholines"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Oxygen"}, {"QualifierName": [], "DescriptorName": "Oxygen Inhalation Therapy"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["blood"], "DescriptorName": "Phosphatidylcholines"}, {"QualifierName": ["blood"], "DescriptorName": "Phosphatidylethanolamines"}, {"QualifierName": ["blood"], "DescriptorName": "Phospholipids"}, {"QualifierName": ["blood"], "DescriptorName": "Sphingomyelins"}, {"QualifierName": [], "DescriptorName": "Veins"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1975", "Month": "1", "Day": "1"}, {"Year": "1975", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1975", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1243775"]}}], "PubmedBookArticle": []}